Automating cell-based assays to determine viral vector titer – Oxford Biomedica & Hamilton Robotics
In this video, Oxford Biomedica (Oxford, UK), an innovative global gene and cell therapy company with operations in the UK and US, describes the automation of an assay requiring a 10 day cell-based workflow, using an integrated Hamilton Microlab STAR liquid handler and CECULA’s Graphical User Interface (GUI).
Download the case study here!
Speakers include:
- Dr Nicholas Clarkson – VP of Research at Oxford Biomedica
- Dr Andre Raposo – Director of Analytics, Platform Research at Oxford Biomedica
- Dr Gabriela Boza-Moran – Senior Field Marketing Team Leader at Hamilton Robotics
In association with
